Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
复制标题
肠易激综合征的肠道微生物源性代谢产物
DOI:
10.3389/fcimb.2021.729346
复制
发表时间:
2021
影响因子:
5.7
通讯作者:
Xiong L
中科院分区:
文献类型:
--
作者:
Xiao L;Liu Q;Luo M;Xiong L
Irritable bowel syndrome (IBS) is the most common functional bowel disorder worldwide and is associated with visceral hypersensitivity, gut motility, immunomodulation, gut microbiota alterations, and dysfunction of the brain-gut axis; however, its pathophysiology remains poorly understood. Gut microbiota and its metabolites are proposed as possible etiological factors of IBS. The aim of our study was to investigate specific types of microbiota-derived metabolites, especially bile acids, short-chain fatty acids, vitamins, amino acids, serotonin and hypoxanthine, which are all implicated in the pathogenesis of IBS. Metabolites-focused research has identified multiple microbial targets relevant to IBS patients, important roles of microbiota-derived metabolites in the development of IBS symptoms have been established. Thus, we provide an overview of gut microbiota and their metabolites on the different subtypes of IBS (constipation-predominant IBS-C, diarrhea-predominant IBS-D) and present controversial views regarding the role of microbiota in IBS.
登录
查看更多内容
影响因子:
2.4
作者:
Farup PG;Rudi K;Hestad K
通讯作者:
Hestad K
DOI:
10.1161/hypertensionaha.114.04035
发表时间:
2015-01
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Biaggioni I;Freeman R;Mathias CJ;Low P;Hewitt LA;Kaufmann H;Droxidopa 302 Investigators
通讯作者:
Droxidopa 302 Investigators
影响因子:
3.5
作者:
Camilleri, M.;Shin, A.;Zinsmeister, A. R.
通讯作者:
Zinsmeister, A. R.
影响因子:
9.8
作者:
Cremon, Cesare;Carini, Giovanni;Barbara, Giovanni
通讯作者:
Barbara, Giovanni
影响因子:
3.4
作者:
Aggarwal S;Ahuja V;Paul J
通讯作者:
Paul J